Canine Idiopathic Epilepsy as a Natural Animal Model for Human Epilepsy: A Scoping Review Highlighting Metabolic Perspectives Beyond the Brain
Nutrients · 28.05.2026 · 18 (11) · 1734
DOI: 10.3390/nu18111734 ↗Kurz gefasst
Scoping Review in der Zeitschrift Nutrients, online erschienen am 28.05.2026. Verfasst von Giulia Cabri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Equine and Companion Animal Nutrition, Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Faculty of Veterinary Medicine, …. Hauptthemen laut MEDLINE: Disease Models, Animal, Epilepsy, Dog Diseases. Die Arbeit nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation - Flanders.
Abstract (Originalsprache)
Background
Emerging evidence indicates that epilepsy extends beyond the brain, involving systemic metabolic, immune, and microbiome perturbations that shape neuronal excitability and treatment response. Canine idiopathic epilepsy (CE) offers a naturally occurring model with strong electrophysiological, pharmacological, and clinical homology to human epilepsies.
Methods
This scoping review was conducted according to the PRISMA-ScR guidelines. A systematic literature search was performed in Web of Science and MEDLINE (PubMed) to identify original studies reporting metabolic, immunometabolic, or neurochemical alterations in CE compared with healthy controls. Eligible studies included peer-reviewed original research involving client-owned dogs diagnosed with CE according to international consensus criteria (IVETF guidelines). Studies focusing exclusively on genetics or neuroimaging without metabolic outcomes were excluded. Titles, abstracts, and full texts were screened for eligibility, and data were extracted from included studies using a standardized approach. Identified metabolic domains were synthesized narratively and grouped into functional systems, including amino acid and lipid metabolism, micronutrients, neurotransmission, oxidative stress, inflammation and immunology, endocannabinoid signalling, microRNAs, and gut–brain axis-related pathways. In a second step, the identified metabolic domains were evaluated for translational relevance through a targeted, non-systematic narrative synthesis of the human epilepsy literature. This approach aimed to assess cross-species parallels and to provide a conceptual framework to guide future research, rather than to perform a comprehensive systematic review of metabolic alterations in human epilepsy.
Results
Across CE studies, consistent alterations were observed in multiple interconnected functional systems, including metabolic, immune, and gut–brain axis pathways, in agreement with findings reported for human epilepsy. These data support a model of epileptogenesis involving systemic dysfunction beyond the central nervous system. Translationally, these findings suggest opportunities for biomarker development, patient stratification, and mechanism-based interventions, including dietary and metabolic approaches (e.g., medium-chain triglyceride supplementation), microbiome modulation, and immunometabolic targeting. The current evidence is limited by small and heterogeneous cohorts, potential confounding effects of antiseizure medications, variability in dietary and fasting conditions, breed-related effects, and a predominance of associative over causal relationships.
Conclusions
This review positions CE as a reference framework for future research into epilepsy metabolism, integrating current evidence and its translational relevance to human disease. The findings support a shift toward a systems-level view of epileptogenesis, involving interconnected metabolic, immune, and gut–brain axis pathways beyond the brain. CE represents a valuable translational model to identify shared mechanisms, inform biomarker discovery, and guide the development of mechanism-based therapeutic strategies across veterinary and human epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Equine and Companion Animal Nutrition, Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke-Melle, Belgium.
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke-Melle, Belgium.
- Laboratory of Integrative Metabolomics (LIMET), Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke-Melle, Belgium.
- Department of Neurology, Ghent University Hospital and 4Brain, Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium.
- Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
ORCID-Profile: Giulia Cabri, Sofie F M Bhatti, Lieselot Y Hemeryck, Paul Boon, Holger A Volk, Myriam Hesta, Fien Verdoodt
Förderung
- Research Foundation - Flanders
Zitieren
APA
Cabri, G., Bhatti, S. F. M., Hemeryck, L. Y., Boon, P., Volk, H. A., Hesta, M., & Verdoodt, F. (2026). Canine Idiopathic Epilepsy as a Natural Animal Model for Human Epilepsy: A Scoping Review Highlighting Metabolic Perspectives Beyond the Brain. Nutrients, 18(11), 1734. https://doi.org/10.3390/nu18111734
Vancouver
Cabri G, Bhatti SFM, Hemeryck LY, Boon P, Volk HA, Hesta M, et al. Canine Idiopathic Epilepsy as a Natural Animal Model for Human Epilepsy: A Scoping Review Highlighting Metabolic Perspectives Beyond the Brain. Nutrients. 2026;18(11):1734. doi:10.3390/nu18111734
BibTeX
@article{Cabri2026,
author = {Cabri, Giulia and Bhatti, Sofie F M and Hemeryck, Lieselot Y and Boon, Paul and Volk, Holger A and Hesta, Myriam and Verdoodt, Fien},
title = {Canine Idiopathic Epilepsy as a Natural Animal Model for Human Epilepsy: A Scoping Review Highlighting Metabolic Perspectives Beyond the Brain},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {11},
pages = {1734},
doi = {10.3390/nu18111734}
}
EUVIMED